Switch to:
Also traded in: Germany, UK, USA

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash-to-Debt 0.12
SNN's Cash-to-Debt is ranked lower than
93% of the 330 Companies
in the Global Medical Devices industry.

( Industry Median: 2.32 vs. SNN: 0.12 )
Ranked among companies with meaningful Cash-to-Debt only.
SNN' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.06  Med: 0.35 Max: 2.58
Current: 0.12
0.06
2.58
Equity-to-Asset 0.59
SNN's Equity-to-Asset is ranked lower than
55% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. SNN: 0.59 )
Ranked among companies with meaningful Equity-to-Asset only.
SNN' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.2  Med: 0.49 Max: 0.7
Current: 0.59
0.2
0.7
Debt-to-Equity 0.31
SNN's Debt-to-Equity is ranked lower than
51% of the 220 Companies
in the Global Medical Devices industry.

( Industry Median: 0.30 vs. SNN: 0.31 )
Ranked among companies with meaningful Debt-to-Equity only.
SNN' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.06  Med: 0.36 Max: 2.23
Current: 0.31
0.06
2.23
Debt-to-EBITDA 1.02
SNN's Debt-to-EBITDA is ranked higher than
66% of the 158 Companies
in the Global Medical Devices industry.

( Industry Median: 1.98 vs. SNN: 1.02 )
Ranked among companies with meaningful Debt-to-EBITDA only.
SNN' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.28  Med: 1.04 Max: 1.66
Current: 1.02
0.28
1.66
Interest Coverage 15.06
SNN's Interest Coverage is ranked lower than
66% of the 212 Companies
in the Global Medical Devices industry.

( Industry Median: 66.37 vs. SNN: 15.06 )
Ranked among companies with meaningful Interest Coverage only.
SNN' s Interest Coverage Range Over the Past 10 Years
Min: 8.87  Med: 15.85 Max: 42.3
Current: 15.06
8.87
42.3
Piotroski F-Score: 7
Altman Z-Score: 4.87
Beneish M-Score: -2.63
WACC vs ROIC
5.14%
13.92%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 19.56
SNN's Operating Margin % is ranked higher than
86% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 1.96 vs. SNN: 19.56 )
Ranked among companies with meaningful Operating Margin % only.
SNN' s Operating Margin % Range Over the Past 10 Years
Min: 13.55  Med: 18.9 Max: 24.61
Current: 19.56
13.55
24.61
Net Margin % 16.05
SNN's Net Margin % is ranked higher than
86% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. SNN: 16.05 )
Ranked among companies with meaningful Net Margin % only.
SNN' s Net Margin % Range Over the Past 10 Years
Min: 8.85  Med: 13.13 Max: 17.43
Current: 16.05
8.85
17.43
ROE % 17.65
SNN's ROE % is ranked higher than
88% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. SNN: 17.65 )
Ranked among companies with meaningful ROE % only.
SNN' s ROE % Range Over the Past 10 Years
Min: 10.47  Med: 19.69 Max: 25.27
Current: 17.65
10.47
25.27
ROA % 9.97
SNN's ROA % is ranked higher than
86% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: -0.26 vs. SNN: 9.97 )
Ranked among companies with meaningful ROA % only.
SNN' s ROA % Range Over the Past 10 Years
Min: 5.79  Med: 9.85 Max: 13.65
Current: 9.97
5.79
13.65
ROC (Joel Greenblatt) % 40.38
SNN's ROC (Joel Greenblatt) % is ranked higher than
82% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 3.87 vs. SNN: 40.38 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
SNN' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 30.86  Med: 43.37 Max: 58.88
Current: 40.38
30.86
58.88
3-Year Revenue Growth Rate 7.40
SNN's 3-Year Revenue Growth Rate is ranked higher than
59% of the 254 Companies
in the Global Medical Devices industry.

( Industry Median: 4.30 vs. SNN: 7.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
SNN' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -4.7  Med: 4.6 Max: 37.8
Current: 7.4
-4.7
37.8
3-Year EBITDA Growth Rate 12.00
SNN's 3-Year EBITDA Growth Rate is ranked higher than
56% of the 232 Companies
in the Global Medical Devices industry.

( Industry Median: 7.50 vs. SNN: 12.00 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
SNN' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -34.1  Med: 6.3 Max: 67.6
Current: 12
-34.1
67.6
3-Year EPS without NRI Growth Rate 22.50
SNN's 3-Year EPS without NRI Growth Rate is ranked higher than
70% of the 223 Companies
in the Global Medical Devices industry.

( Industry Median: 7.80 vs. SNN: 22.50 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
SNN' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 9.1 Max: 44.2
Current: 22.5
0
44.2
GuruFocus has detected 5 Warning Signs with Smith & Nephew PLC SNN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» SNN's 30-Y Financials

Financials (Next Earnings Date: 2018-07-27)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2017

SNN Guru Trades in Q2 2017

Manning & Napier Advisors, Inc 51,789 sh (New)
Steven Cohen 369,900 sh (+3.12%)
Ken Fisher 2,232,591 sh (-1.01%)
Jim Simons 123,700 sh (-83.15%)
» More
Q3 2017

SNN Guru Trades in Q3 2017

Ken Fisher 2,179,610 sh (-2.37%)
Steven Cohen 293,500 sh (-20.65%)
Manning & Napier Advisors, Inc 40,701 sh (-21.41%)
Jim Simons 34,500 sh (-72.11%)
» More
Q4 2017

SNN Guru Trades in Q4 2017

Jim Simons 333,800 sh (+867.54%)
Steven Cohen 297,400 sh (+1.33%)
Ken Fisher 2,128,267 sh (-2.36%)
» More
Q1 2018

SNN Guru Trades in Q1 2018

Steven Cohen 480,650 sh (+61.62%)
Ken Fisher 2,088,062 sh (-1.89%)
Jim Simons 220,350 sh (-33.99%)
» More
» Details

Insider Trades

Latest Guru Trades with SNN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ken Fisher 2018-03-31 Reduce -1.89%$34.12 - $38.45 $ 36.381%2,088,062
Ken Fisher 2017-12-31 Reduce -2.36%$34.62 - $38.5 $ 36.38-0%2,128,267
Ken Fisher 2017-09-30 Reduce -2.37%$33.87 - $37.17 $ 36.382%2,179,610
Ken Fisher 2017-06-30 Reduce -1.01%$30.93 - $35.71 $ 36.388%2,232,591
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339113 
Compare:NAS:ABMD, NAS:ALGN, NYSE:TFX, XSWX:SOON, NYSE:VAR, SZSE:300003, NYSE:ZBH, OCSE:WDH, XPAR:DIM, ASX:COH, NYSE:EW, LSE:CTEC, NZSE:FPH, NYSE:GMED, OCSE:AMBU B, NAS:IART, OCSE:GN, NAS:MASI, OSTO:EKTA B, NYSE:PEN » details
Traded in other countries:NPWA.Germany, SN..UK, SNNUF.USA,
Headquarter Location:UK
Smith & Nephew PLC designs, manufactures, and markets orthopedic devices and wound-care solutions. Its products include knee replacements, hip implants, nails, fixation devices, arthroscopy tools and others.

Smith & Nephew designs, manufactures, and markets orthopedic devices and wound-care solutions. Approximately three fourths of the U.K.-based firm's revenue comes from knee replacements, hip implants, nails, fixation devices, and arthroscopy tools. The remaining 25% of revenue is from the wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from developed European and Asian markets, 40% is from the United States, and emerging markets account for the remainder.

Ratios

vs
industry
vs
history
PE Ratio 20.04
SNN's PE Ratio is ranked higher than
68% of the 180 Companies
in the Global Medical Devices industry.

( Industry Median: 30.17 vs. SNN: 20.04 )
Ranked among companies with meaningful PE Ratio only.
SNN' s PE Ratio Range Over the Past 10 Years
Min: 12.38  Med: 19.25 Max: 43.01
Current: 20.04
12.38
43.01
Forward PE Ratio 19.16
SNN's Forward PE Ratio is ranked higher than
75% of the 52 Companies
in the Global Medical Devices industry.

( Industry Median: 25.06 vs. SNN: 19.16 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 20.04
SNN's PE Ratio without NRI is ranked higher than
69% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 30.17 vs. SNN: 20.04 )
Ranked among companies with meaningful PE Ratio without NRI only.
SNN' s PE Ratio without NRI Range Over the Past 10 Years
Min: 12.38  Med: 19.25 Max: 43.01
Current: 20.04
12.38
43.01
Price-to-Owner-Earnings 18.87
SNN's Price-to-Owner-Earnings is ranked higher than
76% of the 104 Companies
in the Global Medical Devices industry.

( Industry Median: 32.03 vs. SNN: 18.87 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
SNN' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 11.57  Med: 16.28 Max: 48.16
Current: 18.87
11.57
48.16
PB Ratio 3.39
SNN's PB Ratio is ranked lower than
55% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 3.06 vs. SNN: 3.39 )
Ranked among companies with meaningful PB Ratio only.
SNN' s PB Ratio Range Over the Past 10 Years
Min: 2.5  Med: 3.66 Max: 6.76
Current: 3.39
2.5
6.76
PS Ratio 3.31
SNN's PS Ratio is ranked lower than
52% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 3.15 vs. SNN: 3.31 )
Ranked among companies with meaningful PS Ratio only.
SNN' s PS Ratio Range Over the Past 10 Years
Min: 1.44  Med: 2.87 Max: 3.8
Current: 3.31
1.44
3.8
Price-to-Free-Cash-Flow 22.03
SNN's Price-to-Free-Cash-Flow is ranked higher than
66% of the 107 Companies
in the Global Medical Devices industry.

( Industry Median: 26.44 vs. SNN: 22.03 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
SNN' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 14.01  Med: 23.16 Max: 55.66
Current: 22.03
14.01
55.66
Price-to-Operating-Cash-Flow 14.46
SNN's Price-to-Operating-Cash-Flow is ranked higher than
70% of the 127 Companies
in the Global Medical Devices industry.

( Industry Median: 20.01 vs. SNN: 14.46 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
SNN' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.87  Med: 13.93 Max: 29.65
Current: 14.46
8.87
29.65
EV-to-EBIT 17.73
SNN's EV-to-EBIT is ranked higher than
61% of the 174 Companies
in the Global Medical Devices industry.

( Industry Median: 24.76 vs. SNN: 17.73 )
Ranked among companies with meaningful EV-to-EBIT only.
SNN' s EV-to-EBIT Range Over the Past 10 Years
Min: 8.3  Med: 14.5 Max: 30.7
Current: 17.73
8.3
30.7
EV-to-EBITDA 12.02
SNN's EV-to-EBITDA is ranked higher than
70% of the 188 Companies
in the Global Medical Devices industry.

( Industry Median: 18.14 vs. SNN: 12.02 )
Ranked among companies with meaningful EV-to-EBITDA only.
SNN' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.5  Med: 10.2 Max: 19.2
Current: 12.02
6.5
19.2
EV-to-Revenue 3.50
SNN's EV-to-Revenue is ranked higher than
52% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 3.73 vs. SNN: 3.50 )
Ranked among companies with meaningful EV-to-Revenue only.
SNN' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.8  Med: 3.1 Max: 4.2
Current: 3.5
1.8
4.2
PEG Ratio 2.56
SNN's PEG Ratio is ranked lower than
52% of the 77 Companies
in the Global Medical Devices industry.

( Industry Median: 2.53 vs. SNN: 2.56 )
Ranked among companies with meaningful PEG Ratio only.
SNN' s PEG Ratio Range Over the Past 10 Years
Min: 0.42  Med: 0.94 Max: 16.73
Current: 2.56
0.42
16.73
Shiller PE Ratio 28.72
SNN's Shiller PE Ratio is ranked higher than
78% of the 58 Companies
in the Global Medical Devices industry.

( Industry Median: 49.95 vs. SNN: 28.72 )
Ranked among companies with meaningful Shiller PE Ratio only.
SNN' s Shiller PE Ratio Range Over the Past 10 Years
Min: 21.48  Med: 30.11 Max: 48.5
Current: 28.72
21.48
48.5
Current Ratio 2.03
SNN's Current Ratio is ranked lower than
66% of the 324 Companies
in the Global Medical Devices industry.

( Industry Median: 2.71 vs. SNN: 2.03 )
Ranked among companies with meaningful Current Ratio only.
SNN' s Current Ratio Range Over the Past 10 Years
Min: 0.84  Med: 1.57 Max: 2.42
Current: 2.03
0.84
2.42
Quick Ratio 1.06
SNN's Quick Ratio is ranked lower than
79% of the 324 Companies
in the Global Medical Devices industry.

( Industry Median: 2.03 vs. SNN: 1.06 )
Ranked among companies with meaningful Quick Ratio only.
SNN' s Quick Ratio Range Over the Past 10 Years
Min: 0.47  Med: 1.02 Max: 1.35
Current: 1.06
0.47
1.35
Days Inventory 381.19
SNN's Days Inventory is ranked lower than
89% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 143.61 vs. SNN: 381.19 )
Ranked among companies with meaningful Days Inventory only.
SNN' s Days Inventory Range Over the Past 10 Years
Min: 253.11  Med: 323.1 Max: 386.02
Current: 381.19
253.11
386.02
Days Sales Outstanding 79.07
SNN's Days Sales Outstanding is ranked lower than
62% of the 276 Companies
in the Global Medical Devices industry.

( Industry Median: 69.21 vs. SNN: 79.07 )
Ranked among companies with meaningful Days Sales Outstanding only.
SNN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 73.96  Med: 79.59 Max: 92.28
Current: 79.07
73.96
92.28
Days Payable 249.66
SNN's Days Payable is ranked lower than
99.99% of the 261 Companies
in the Global Medical Devices industry.

( Industry Median: 58.34 vs. SNN: 249.66 )
Ranked among companies with meaningful Days Payable only.
SNN' s Days Payable Range Over the Past 10 Years
Min: 175.78  Med: 225.97 Max: 258.02
Current: 249.66
175.78
258.02

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.92
SNN's Dividend Yield % is ranked higher than
74% of the 212 Companies
in the Global Medical Devices industry.

( Industry Median: 1.12 vs. SNN: 1.92 )
Ranked among companies with meaningful Dividend Yield % only.
SNN' s Dividend Yield % Range Over the Past 10 Years
Min: 0.83  Med: 1.66 Max: 2.3
Current: 1.92
0.83
2.3
Dividend Payout Ratio 0.35
SNN's Dividend Payout Ratio is ranked higher than
84% of the 126 Companies
in the Global Medical Devices industry.

( Industry Median: 0.32 vs. SNN: 0.35 )
Ranked among companies with meaningful Dividend Payout Ratio only.
SNN' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.22  Med: 0.32 Max: 0.68
Current: 0.35
0.22
0.68
3-Year Dividend Growth Rate 8.50
SNN's 3-Year Dividend Growth Rate is ranked lower than
55% of the 75 Companies
in the Global Medical Devices industry.

( Industry Median: 9.70 vs. SNN: 8.50 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
SNN' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 6.7 Max: 82.3
Current: 8.5
0
82.3
Forward Dividend Yield % 1.92
SNN's Forward Dividend Yield % is ranked higher than
71% of the 203 Companies
in the Global Medical Devices industry.

( Industry Median: 1.48 vs. SNN: 1.92 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 3.54
SNN's 5-Year Yield-on-Cost % is ranked higher than
81% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: 1.52 vs. SNN: 3.54 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
SNN' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.53  Med: 3.06 Max: 4.24
Current: 3.54
1.53
4.24
3-Year Average Share Buyback Ratio 0.70
SNN's 3-Year Average Share Buyback Ratio is ranked higher than
96% of the 244 Companies
in the Global Medical Devices industry.

( Industry Median: -5.70 vs. SNN: 0.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
SNN' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -2.8  Med: -0.4 Max: 20.3
Current: 0.7
-2.8
20.3

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 17.41
SNN's Price-to-Tangible-Book is ranked lower than
88% of the 276 Companies
in the Global Medical Devices industry.

( Industry Median: 4.50 vs. SNN: 17.41 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
SNN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 5.23  Med: 11.67 Max: 62.53
Current: 17.41
5.23
62.53
Price-to-Intrinsic-Value-Projected-FCF 1.58
SNN's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
74% of the 121 Companies
in the Global Medical Devices industry.

( Industry Median: 2.44 vs. SNN: 1.58 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
SNN' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.08  Med: 4.12 Max: 15.2
Current: 1.58
1.08
15.2
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.44
SNN's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
78% of the 27 Companies
in the Global Medical Devices industry.

( Industry Median: 2.06 vs. SNN: 1.44 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
SNN' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.48  Med: 0.67 Max: 4.19
Current: 1.44
0.48
4.19
Price-to-Median-PS-Value 1.15
SNN's Price-to-Median-PS-Value is ranked lower than
59% of the 237 Companies
in the Global Medical Devices industry.

( Industry Median: 1.02 vs. SNN: 1.15 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
SNN' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.53  Med: 1.23 Max: 2.71
Current: 1.15
0.53
2.71
Price-to-Peter-Lynch-Fair-Value 2.60
SNN's Price-to-Peter-Lynch-Fair-Value is ranked lower than
60% of the 47 Companies
in the Global Medical Devices industry.

( Industry Median: 2.05 vs. SNN: 2.60 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
SNN' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.62  Med: 2.07 Max: 9.77
Current: 2.6
0.62
9.77
Price-to-Graham-Number 3.95
SNN's Price-to-Graham-Number is ranked lower than
74% of the 133 Companies
in the Global Medical Devices industry.

( Industry Median: 2.11 vs. SNN: 3.95 )
Ranked among companies with meaningful Price-to-Graham-Number only.
SNN' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.88  Med: 4.07 Max: 9.77
Current: 3.95
1.88
9.77
Earnings Yield (Greenblatt) % 5.63
SNN's Earnings Yield (Greenblatt) % is ranked higher than
80% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: 0.74 vs. SNN: 5.63 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
SNN' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 3.3  Med: 6.9 Max: 12.1
Current: 5.63
3.3
12.1
Forward Rate of Return (Yacktman) % 11.10
SNN's Forward Rate of Return (Yacktman) % is ranked higher than
60% of the 125 Companies
in the Global Medical Devices industry.

( Industry Median: 6.60 vs. SNN: 11.10 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
SNN' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 0.2  Med: 19.4 Max: 22.5
Current: 11.1
0.2
22.5

More Statistics

Revenue (TTM) (Mil) $4,765.00
EPS (TTM) $ 1.75
Beta0.33
Volatility14.48%
52-Week Range $33.72 - 40.43
Shares Outstanding (Mil)437.23 (ADR)

Analyst Estimate

Dec18 Dec19 Dec20
Revenue (Mil $) 5,024 5,207 5,370
EBIT (Mil $) 901 1,057 1,108
EBITDA (Mil $) 1,379 1,528 1,606
EPS ($) 1.66 1.85 2.19
EPS without NRI ($) 1.66 1.85 2.19
EPS Growth Rate
(Future 3Y To 5Y Estimate)
7.73%
Dividends per Share ($) 0.67 0.72 0.83

Piotroski F-Score Details

Piotroski F-Score: 77
Positive ROAY
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyY
Less Shares Outstanding yoyY
Higher Gross Margin yoyY
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}